Publications

Publications from OUS - Chronic Infections Research Group

292 publications found

Publications 2021

Aamodt AH, Høgestøl EA, Popperud TH, Holter JC, Dyrhol-Riise AM, Tonby K, Stiksrud B, Quist-Paulsen E, Berge T, Barratt-Due A, Aukrust P, Heggelund L, Blennow K, Zetterberg H, Harbo HF (2021)
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
J Neurol
DOI 10.1007/s00415-021-10517-6, PubMed 33743046
Amundsen EK, Binde C, Christensen EE, Klingenberg O, Kvale D, Holten AR (2021)
Prognostic Value of Nucleated RBCs for Patients With Suspected Sepsis in the Emergency Department: A Single-Center Prospective Cohort Study
Crit Care Explor, 3 (7), e0490
DOI 10.1097/CCE.0000000000000490, PubMed 34291222
Barratt-Due A, Olsen IC, Nezvalova-Henriksen K, Kåsine T, Lund-Johansen F, Hoel H, Holten AR, Tveita A, Mathiessen A, Haugli M, Eiken R, Kildal AB, Berg Å, Johannessen A, Heggelund L, Dahl TB, Skåra KH, Mielnik P, Kieu Le LA, Thoresen L, Ernst G, Lihaug Hoff DA, Skudal H, Kittang BR, Olsen RB et al. (2021)
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial
Ann Intern Med (in press)
DOI 10.7326/M21-0653, PubMed 34251903
Chendi BH, Snyders CI, Tonby K, Jenum S, Kidd M, Walzl G, Chegou NN, Dyrhol-Riise AM (2021)
A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
Front Immunol, 12, 608846
DOI 10.3389/fimmu.2021.608846, PubMed 33732236
Chendi BH, Tveiten H, Snyders CI, Tonby K, Jenum S, Nielsen SD, Hove-Skovsgaard M, Walzl G, Chegou NN, Dyrhol-Riise AM (2021)
CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries
J Infect (in press)
DOI 10.1016/j.jinf.2021.07.036, PubMed 34333033
Christensen EE, Jørgensen MJ, Nore KG, Dahl TB, Yang K, Ranheim T, Huse C, Lind A, Nur S, Stiksrud B, Jenum S, Tonby K, Holter JC, Holten AR, Halvorsen B, Dyrhol-Riise AM (2021)
Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns
J Intern Med, 290 (3), 677-692
DOI 10.1111/joim.13310, PubMed 34080738
Jøntvedt Jørgensen M, Nore KG, Aass HCD, Layre E, Nigou J, Mortensen R, Tasken K, Kvale D, Jenum S, Tonby K, Dyrhol-Riise AM (2021)
Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients
Front Cell Infect Microbiol, 11, 669623
DOI 10.3389/fcimb.2021.669623, PubMed 34307194
Kolberg ES, Wickstrøm K, Tonby K, Dyrhol-Riise AM, Holten AR, Amundsen EK (2021)
Serum ACE as a prognostic biomarker in COVID-19: a case series
APMIS, 129 (4), 237-238
DOI 10.1111/apm.13108, PubMed 33368687
Kristiansen T, Pettersen FO, Lier T, Hinderaker SG, Greve G, Mørch K (2021)
Schistosomiasis in Norwegian students after travel to Africa
Tidsskr Nor Laegeforen, 141 (3)
DOI 10.4045/tidsskr.20.0268, PubMed 33624965
Lerum TV, Aaløkken TM, Brønstad E, Aarli B, Ikdahl E, Lund KMA, Durheim MT, Rodriguez JR, Meltzer C, Tonby K, Stavem K, Skjønsberg OH, Ashraf H, Einvik G (2021)
Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19
Eur Respir J, 57 (4)
DOI 10.1183/13993003.03448-2020, PubMed 33303540
Lundin KEA, Røsjø H, Myhren H, Kvale D, Rosvold EO (2021)
Legeutdanning i en pandemitid
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0581, PubMed 34505488
Nissen-Meyer LSH, Brantsæter AB (2021)
The story of an extraordinary year: Challenges and opportunities in responding to Covid-19
Transfus Apher Sci, 60 (2), 103092
DOI 10.1016/j.transci.2021.103092, PubMed 33612447
Nydal SM, Munyaw Y, Bruun JN, Brantsæter AB (2021)
Achievements and Challenges in the Prevention of Mother-to-Child Transmission of HIV-A Retrospective Cohort Study from a Rural Hospital in Northern Tanzania
Int J Environ Res Public Health, 18 (5)
DOI 10.3390/ijerph18052751, PubMed 33803114
Sigfrid L, Cevik M, Jesudason E, Lim WS, Rello J, Amuasi J, Bozza F, Palmieri C, Munblit D, Holter JC, Kildal AB, Reyes LF, Russell CD, Ho A, Turtle L, Drake TM, Beltrame A, Hann K, Bangura IR, Fowler R, Lakoh S, Berry C, Lowe DJ, McPeake J, Hashmi M et al. (2021)
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol
BMJ Open, 11 (3), e043887
DOI 10.1136/bmjopen-2020-043887, PubMed 33692181
Sivakumaran D, Blatner G, Bakken R, Hokey D, Ritz C, Jenum S, Grewal HMS (2021)
A 2-Dose AERAS-402 Regimen Boosts CD8⁺ Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients
Front Immunol, 12, 673532
DOI 10.3389/fimmu.2021.673532, PubMed 34177914
Sivakumaran D, Ritz C, Gjøen JE, Vaz M, Selvam S, Ottenhoff THM, Doherty TM, Jenum S, Grewal HMS (2021)
Host Blood RNA Transcript and Protein Signatures for Sputum-Independent Diagnostics of Tuberculosis in Adults
Front Immunol, 11, 626049
DOI 10.3389/fimmu.2020.626049, PubMed 33613569
Watne LO, Tonby K, Holten AR, Olasveengen TM, Romundstad LG, Neerland BE (2021)
Delirium is common in patients hospitalized with COVID-19
Intern Emerg Med
DOI 10.1007/s11739-021-02715-x, PubMed 33830418
Wickstrøm KE, Vitelli V, Carr E, Holten AR, Bendayan R, Reiner AH, Bean D, Searle T, Shek A, Kraljevic Z, Teo J, Dobson R, Tonby K, Köhn-Luque A, Amundsen EK (2021)
Regional performance variation in external validation of four prediction models for severity of COVID-19 at hospital admission: An observational multi-centre cohort study
PLoS One, 16 (8), e0255748
DOI 10.1371/journal.pone.0255748, PubMed 34432797

Publications 2020

Bekken GK, Ritz C, Selvam S, Jesuraj N, Hesseling AC, Doherty TM, Grewal HMS, Vaz M, Jenum S (2020)
Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations
BMC Infect Dis, 20 (1), 96
DOI 10.1186/s12879-020-4800-y, PubMed 32005136
Borén HK, Thaulow CM, Quist-Paulsen E, Wæhre T, Akselsen PE, Tonby K (2020)
Antibiotic use in hospitals in cases of COVID-19
Tidsskr Nor Laegeforen, 140 (11)
DOI 10.4045/tidsskr.20.0443, PubMed 32815355
Brantsaeter AB (2020)
Experimental treatment in COVID-19
Tidsskr. Nor. Laegeforen., 140 (12), 1211
Gundem T, Olasveengen TM, Hovda KE, Gaustad K, Schøndorf C, Rostrup M, Frøyshov S, Undseth Ø, Tonby K, Holten AR, Sunde K (2020)
Ventilatory support for hypoxaemic intensive care patients with COVID-19
Tidsskr Nor Laegeforen, 140 (11)
DOI 10.4045/tidsskr.20.0445, PubMed 32815344
Hoel H, Heggelund L, Reikvam DH, Stiksrud B, Ueland T, Michelsen AE, Otterdal K, Muller KE, Lind A, Muller F, Dudman S, Aukrust P, Dyrhol-Riise AM, Holter JC, Trøseid M (2020)
Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement
J Intern Med, 289 (4), 523-531
DOI 10.1111/joim.13178, PubMed 32976665
Hoel IM, Sviland L, Syre H, Dyrhol-Riise AM, Skarstein I, Jebsen P, Jørstad MD, Wiker H, Mustafa T (2020)
Diagnosis of extrapulmonary tuberculosis using the MPT64 antigen detection test in a high-income low tuberculosis prevalence setting
BMC Infect Dis, 20 (1), 130
DOI 10.1186/s12879-020-4852-z, PubMed 32050915
Holten AR, Nore KG, Tveiten CEVWK, Olasveengen TM, Tonby K (2020)
Predicting severe COVID-19 in the Emergency Department
Resusc Plus, 4, 100042
DOI 10.1016/j.resplu.2020.100042, PubMed 33403367
Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, Tonby K, Barratt-Due A, Sokolova M, Schjalm C, Chaban V, Kolderup A, Tran T, Tollefsrud Gjølberg T, Skeie LG, Hesstvedt L, Ormåsen V, Fevang B, Austad C, Müller KE, Fladeby C, Holberg-Petersen M, Halvorsen B, Müller F, Aukrust P et al. (2020)
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Proc Natl Acad Sci U S A, 117 (40), 25018-25025
DOI 10.1073/pnas.2010540117, PubMed 32943538
Jøntvedt Jørgensen M, Holter JC, Christensen EE, Schjalm C, Tonby K, Pischke SE, Jenum S, Skeie LG, Nur S, Lind A, Opsand H, Enersen TB, Grøndahl R, Hermann A, Dudman S, Muller F, Ueland T, Mollnes TE, Aukrust P, Heggelund L, Holten AR, Dyrhol-Riise AM (2020)
Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
Sci Rep, 10 (1), 21697
DOI 10.1038/s41598-020-78710-7, PubMed 33303843
Jøntvedt Jørgensen M, Jenum S, Tonby K, Mortensen R, Walzl G, Du Plessis N, Dyrhol-Riise AM (2020)
Monocytic myeloid-derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase-2 inhibitors
J Leukoc Biol, 110 (1), 177-186
DOI 10.1002/JLB.4A0720-409RR, PubMed 33155730
Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rangberg A, Jonassen CM, Omland T, Røsjø H, Dalgard O (2020)
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial
Trials, 21 (1), 485
DOI 10.1186/s13063-020-04420-0, PubMed 32503662
Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rueegg CS, Rangberg A, Jonassen CM, Omland T, Røsjø H, Dalgard O (2020)
A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
Nat Commun, 11 (1), 5284
DOI 10.1038/s41467-020-19056-6, PubMed 33082342
Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Stiksrud B, Trøseid M, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Reikvam DH (2020)
HIV-infected immunological non-responders have colon-restricted gut mucosal immune dysfunction
J Infect Dis (in press)
DOI 10.1093/infdis/jiaa714, PubMed 33216130
Mustafa T, Wergeland I, Baba K, Pathak S, Hoosen AA, Dyrhol-Riise AM (2020)
Mycobacterial antigens in pleural fluid mononuclear cells to diagnose pleural tuberculosis in HIV co-infected patients
BMC Infect Dis, 20 (1), 459
DOI 10.1186/s12879-020-05165-6, PubMed 32611401
Nore KG, Jørgensen MJ, Dyrhol-Riise AM, Jenum S, Tonby K (2020)
Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
Front Immunol, 11, 579849
DOI 10.3389/fimmu.2020.579849, PubMed 33304347
Reikvam DH, Meyer-Myklestad MH, Trøseid M, Stiksrud B (2020)
Probiotics to manage inflammation in HIV infection
Curr Opin Infect Dis, 33 (1), 34-43
DOI 10.1097/QCO.0000000000000612, PubMed 31789692
Sivakumaran D, Jenum S, Vaz M, Selvam S, Ottenhoff THM, Haks MC, Malherbe ST, Doherty TM, Ritz C, Grewal HMS (2020)
Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes
Commun Biol, 3 (1), 359
DOI 10.1038/s42003-020-1087-x, PubMed 32647325
Trøseid M, Lutro O, Ormaasen V (2020)
Experimental treatment for COVID-19 should be undertaken in randomised studies
Tidsskr Nor Laegeforen, 140 (7)
DOI 10.4045/tidsskr.20.0282, PubMed 32378863
Ueland T, Heggelund L, Lind A, Holten AR, Tonby K, Michelsen AE, Jenum S, Jørgensen MJ, Barratt-Due A, Skeie LG, Nordøy I, Aanensen Fraz MS, Quist-Paulsen E E, Pischke SE, Johal SK, Hesstvedt L, Bogen M, Fevang B, Halvorsen B, Müller F, Bekken GK, Mollnes TE, Dudman S, Aukrust P, Dyrhol-Riise AM et al. (2020)
Elevated plasma sTIM-3 levels in patients with severe COVID-19
J Allergy Clin Immunol, 147 (1), 92-98
DOI 10.1016/j.jaci.2020.09.007, PubMed 32971109
Ueland T, Holter JC, Holten AR, Müller KE, Lind A, Bekken GK, Dudman S, Aukrust P, Dyrhol-Riise AM, Heggelund L (2020)
Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure
J Infect, 81 (3), e41-e43
DOI 10.1016/j.jinf.2020.06.061, PubMed 32603675
Whittaker R, Nilsen O, Myrberg AJ, Angeltvedt RM, Bergersen BM, Klovstad H (2020)
Norway is in the process of stopping the HIV epidemic
Tidsskr. Nor. Laegeforen., 140 (18), 1864-1866

Publications 2019

Arnesen TM, Brantsæter AB, Nøkleby H (2019)
Bacille Calmette-Guérin vaccination of healthcare personnel: changing epidemiology calls for new recommendations in Norway
Eur Respir J, 53 (1)
DOI 10.1183/13993003.01123-2018, PubMed 30630851
Dukic AR, Gerbaud P, Guibourdenche J, Thiede B, Taskén K, Pidoux G (2019)
Correction: Ezrin-anchored PKA phosphorylates serine 369 and 373 on connexin 43 to enhance gap junction assembly, communication, and cell fusion
Biochem J, 476 (13), 1927
DOI 10.1042/BCJ-2017-0529_COR, PubMed 31266855
Hoel IM, Jørstad MD, Marijani M, Ruhwald M, Mustafa T, Dyrhol-Riise AM (2019)
IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting
Sci Rep, 9 (1), 3871
DOI 10.1038/s41598-019-40458-0, PubMed 30846768
Jørstad MD, Dyrhol-Riise AM, Aßmus J, Marijani M, Sviland L, Mustafa T (2019)
Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting
BMC Infect Dis, 19 (1), 426
DOI 10.1186/s12879-019-4034-z, PubMed 31096926
Maltezou HC, Botelho-Nevers E, Brantsæter AB, Carlsson RM, Heininger U, Hübschen JM, Josefsdottir KS, Kassianos G, Kyncl J, Ledda C, Medić S, Nitsch-Osuch A, de Lejarazu RO, Theodoridou M, Van Damme P, van Essen GA, Wicker S, Wiedermann U, Poland GA, Vaccination Policies for HCP in Europe Study Group (2019)
Vaccination of healthcare personnel in Europe: Update to current policies
Vaccine, 37 (52), 7576-7584
DOI 10.1016/j.vaccine.2019.09.061, PubMed 31623916
Mirinaviciute G, Quist-Paulsen E, Brantsæter AB, Flem E (2019)
The burden of herpes zoster disease in Norway
Vaccine, 38 (18), 3501-3507
DOI 10.1016/j.vaccine.2019.11.054, PubMed 31843267
Mortensen R, Clemmensen HS, Woodworth JS, Therkelsen ML, Mustafa T, Tonby K, Jenum S, Agger EM, Dyrhol-Riise AM, Andersen P (2019)
Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice
Commun Biol, 2, 288
DOI 10.1038/s42003-019-0530-3, PubMed 31396568
Quist-Paulsen E, Kran AB, Lindland ES, Ellefsen K, Sandvik L, Dunlop O, Ormaasen V (2019)
To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study
BMC Infect Dis, 19 (1), 80
DOI 10.1186/s12879-018-3570-2, PubMed 30669985
Quist-Paulsen E, Ormaasen V, Kran AB, Dunlop O, Ueland PM, Ueland T, Eikeland R, Aukrust P, Nordenmark TH (2019)
Encephalitis and aseptic meningitis: short-term and long-term outcome, quality of life and neuropsychological functioning
Sci Rep, 9 (1), 16158
DOI 10.1038/s41598-019-52570-2, PubMed 31695095
Schwartz T, Jensenius M, Blomberg B, Fladeby C, Mæland A, Pettersen FO (2019)
Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients
Trop Dis Travel Med Vaccines, 5, 16
DOI 10.1186/s40794-019-0092-x, PubMed 31463070
Steens A, Winje BA, White RA, Odsbu I, Brantsæter AB, Vestrheim DF (2019)
Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-cohort Study
Clin Infect Dis, 68 (8), 1367-1373
DOI 10.1093/cid/ciy714, PubMed 30957160
Stiksrud B, Aass HCD, Lorvik KB, Ueland T, Trøseid M, Dyrhol-Riise AM (2019)
Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery
AIDS, 33 (7), 1117-1129
DOI 10.1097/QAD.0000000000002173, PubMed 30789356
Storm-Larsen C, Stiksrud B, Eriksen C, Nowak P, Holm K, Thalme A, Dyrhol-Riise AM, Brix S, Hov JR, Trøseid M (2019)
Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals
AIDS, 33 (4), 645-653
DOI 10.1097/QAD.0000000000002087, PubMed 30531315
Tonby K, Mortensen R, Ruhwald M, Dyrhol-Riise AM, Jenum S (2019)
KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment
J Infect Dis, 220 (1), 174-176
DOI 10.1093/infdis/jiz056, PubMed 30888024
Waehre T, Petterson FO (2019)
HIV medicines on offer gives worse treatment options
Tidsskr. Nor. Laegeforen., 139 (2), 121-122

Publications 2018

Habtamu M, Abebe M, Aseffa A, Dyrhol-Riise AM, Spurkland A, Abrahamsen G (2018)
In vitro analysis of antigen induced T cell-monocyte conjugates by imaging flow cytometry
J Immunol Methods, 460, 93-100
DOI 10.1016/j.jim.2018.06.014, PubMed 29981305
Henjum K, Quist-Paulsen E, Zetterberg H, Blennow K, Nilsson LNG, Watne LO (2018)
CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau
J Neuroinflammation, 15 (1), 304
DOI 10.1186/s12974-018-1331-1, PubMed 30390679
Jenum S, Selvam S, Jesuraj N, Ritz C, Hesseling AC, Cardenas V, Lau E, Doherty TM, Grewal HMS, Vaz M (2018)
Incidence of tuberculosis and the influence of surveillance strategy on tuberculosis case-finding and all-cause mortality: a cluster randomised trial in Indian neonates vaccinated with BCG
BMJ Open Respir Res, 5 (1), e000304
DOI 10.1136/bmjresp-2018-000304, PubMed 30397482
Jørstad MD, Marijani M, Dyrhol-Riise AM, Sviland L, Mustafa T (2018)
MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar
PLoS One, 13 (5), e0196723
DOI 10.1371/journal.pone.0196723, PubMed 29742144
Lindland ES, Solheim AM, Andreassen S, Quist-Paulsen E, Eikeland R, Ljøstad U, Mygland Å, Elsais A, Nygaard GO, Lorentzen ÅR, Harbo HF, Beyer MK (2018)
Imaging in Lyme neuroborreliosis
Insights Imaging, 9 (5), 833-844
DOI 10.1007/s13244-018-0646-x, PubMed 30187265
Mocroft A, Laut K, Reiss P, Gatell J, Ormaasen V, Cavassini M, Hadziosmanovic V, Mansinho K, Pradier C, Vasylyev M, Mitsura V, Vandekerckhove L, Ostergaard L, Clarke A, Degen O, Mulcahy F, Castagna A, Sthoeger Z, Flamholc L, Sedláček D, Mozer-Lisewska I, Lundgren JD, EuroSIDA Study (2018)
Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
AIDS, 32 (2), 205-215
DOI 10.1097/QAD.0000000000001684, PubMed 29112060
Myhrvold IK, Cremaschi A, Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia
Oncotarget, 9 (10), 9273-9284
DOI 10.18632/oncotarget.23949, PubMed 29507689
Naess-Andresen K, Sorsvang L, Berntzen LS, Waehre T (2018)
Pregnant HIV positive must be followed closely
Tidsskr. Nor. Laegeforen., 138 (11), 998-999
Orlien SMS, Ismael NY, Ahmed TA, Berhe N, Lauritzen T, Roald B, Goldin RD, Stene-Johansen K, Dyrhol-Riise AM, Gundersen SG, Morgan MY, Johannessen A (2018)
Unexplained chronic liver disease in Ethiopia: a cross-sectional study
BMC Gastroenterol, 18 (1), 27
DOI 10.1186/s12876-018-0755-5, PubMed 29439653
Pelchen-Matthews A, Ryom L, Borges ÁH, Edwards S, Duvivier C, Stephan C, Sambatakou H, Maciejewska K, Portu JJ, Weber J, Degen O, Calmy A, Reikvam DH, Jevtovic D, Wiese L, Smidt J, Smiatacz T, Hassoun G, Kuznetsova A, Clotet B, Lundgren J, Mocroft A, EuroSIDA study (2018)
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort
AIDS, 32 (16), 2405-2416
DOI 10.1097/QAD.0000000000001967, PubMed 30134296
Quist-Paulsen E, Aukrust P, Kran AB, Dunlop O, Ormaasen V, Stiksrud B, Midttun Ø, Ueland T, Ueland PM, Mollnes TE, Dyrhol-Riise AM (2018)
High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
J Neuroinflammation, 15 (1), 327
DOI 10.1186/s12974-018-1366-3, PubMed 30470234
Sane Schepisi M, Navarra A, Altet Gomez MN, Dudnyk A, Dyrhol-Riise AM, Esteban J, Giorgetti PF, Gualano G, Guglielmetti L, Heyckendorf J, Kaluzhenina A, Lange B, Lange C, Manika K, Miah J, Nanovic Z, Pontali E, Prego MR, Solovic I, Tiberi S, Palmieri F, Girardi E (2018)
Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study
Open Forum Infect Dis, 6 (1), ofy337
DOI 10.1093/ofid/ofy337, PubMed 30697572
Schein YL, Madebo T, Andersen HE, Arnesen TM, Dyrhol-Riise AM, Tveiten H, White RA, Winje BA (2018)
Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study
BMC Infect Dis, 18 (1), 587
DOI 10.1186/s12879-018-3468-z, PubMed 30453946
Tveiten H, Brantsæter AB, Mengshoel AT (2018)
Non-tuberculous mycobacterial pulmonary infections
Tidsskr Nor Laegeforen, 138 (19)
DOI 10.4045/tidsskr.18.0077, PubMed 30497255
Ursin Rein P, Jacobsen D, Ormaasen V, Dunlop O (2018)
Pneumococcal sepsis requiring mechanical ventilation: Cohort study in 38 patients with rapid progression to septic shock
Acta Anaesthesiol Scand, 62 (10), 1428-1435
DOI 10.1111/aas.13236, PubMed 30132782
Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM (2018)
Stratification by interferon-γ release assay level predicts risk of incident TB
Thorax, 73 (7), 652-661
DOI 10.1136/thoraxjnl-2017-211147, PubMed 29622693

Publications 2017

Brekke K, Sommerfelt M, Ökvist M, Dyrhol-Riise AM, Kvale D (2017)
The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
BMC Infect Dis, 17 (1), 228
DOI 10.1186/s12879-017-2316-x, PubMed 28340570
Chellappa S, Hugenschmidt H, Hagness M, Subramani S, Melum E, Line PD, Labori KJ, Wiedswang G, Taskén K, Aandahl EM (2017)
CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer
J Immunol, 198 (4), 1729-1739
DOI 10.4049/jimmunol.1600061, PubMed 28053236
Dukic AR, Haugen LH, Pidoux G, Leithe E, Bakke O, Taskén K (2017)
A protein kinase A-ezrin complex regulates connexin 43 gap junction communication in liver epithelial cells
Cell Signal, 32, 1-11
DOI 10.1016/j.cellsig.2017.01.008, PubMed 28077322
Feruglio SL, Kvale D, Dyrhol-Riise AM (2017)
T Cell Responses and Regulation and the Impact of In Vitro IL-10 and TGF-β Modulation During Treatment of Active Tuberculosis
Scand J Immunol, 85 (2), 138-146
DOI 10.1111/sji.12511, PubMed 27862137
Gjøen JE, Jenum S, Sivakumaran D, Mukherjee A, Macaden R, Kabra SK, Lodha R, Ottenhoff THM, Haks MC, Doherty TM, Ritz C, Grewal HMS (2017)
Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children
Sci Rep, 7 (1), 5839
DOI 10.1038/s41598-017-05057-x, PubMed 28724962
Manner IW, Waldum-Grevbo B, Witczak BN, Bækken M, Øktedalen O, Os I, Schwartz T, Sjaastad I (2017)
Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients
Blood Press, 26 (6), 332-340
DOI 10.1080/08037051.2017.1346459, PubMed 28675304
Musingwini TV, Zhou DT, Mhandire D, Duri K, Gomo E, Oktedalen O, Chimukangara B, Shamu T, Shawarira-Bote S, Dandara C, Stray-Pedersen B (2017)
Use of Proviral DNA to Investigate Virus Resistance Mutations in HIV-infected Zimbabweans
Open Microbiol J, 11, 45-52
DOI 10.2174/1874285801711010045, PubMed 28553415
Muswe R, Oktedalen O, Zhou DT, Zinyando E, Shawarira-Bote S, Stray-Pedersen B, Siziba A, Gomo ZAR (2017)
Inflammatory Markers and Plasma Lipids in HIV Patients: A Correlation Analysis Study
Open Biochem J, 11, 105-118
DOI 10.2174/1874091X01711010105, PubMed 29387269
Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
PLoS One, 12 (5), e0176527
DOI 10.1371/journal.pone.0176527, PubMed 28464042
van Santen DK, van der Helm JJ, Del Amo J, Meyer L, D'Arminio Monforte A, Price M, Béguelin CA, Zangerle R, Sannes M, Porter K, Geskus RB, Prins M, CASCADE Collaboration in EuroCoord (2017)
Lack of decline in hepatitis C virus incidence among HIV-positive men who have sex with men during 1990-2014
J Hepatol, 67 (2), 255-262
DOI 10.1016/j.jhep.2017.03.038, PubMed 28412290

Publications 2016

Bains SJ, Mahic M, Myklebust TÅ, Småstuen MC, Yaqub S, Dørum LM, Bjørnbeth BA, Møller B, Brudvik KW, Taskén K (2016)
Reply to M. Løberg et al
J Clin Oncol, 35 (5), 569-571
DOI 10.1200/JCO.2016.70.8263, PubMed 29236616
Bains SJ, Mahic M, Myklebust TÅ, Småstuen MC, Yaqub S, Dørum LM, Bjørnbeth BA, Møller B, Brudvik KW, Taskén K (2016)
Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study
J Clin Oncol, 34 (21), 2501-8
DOI 10.1200/JCO.2015.65.3519, PubMed 27247217
Bates M, Brantsaeter AB (2016)
Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
J Virus Erad, 2 (3), 136-42
PubMed 27482452
Dukic AR, McClymont DW, Taskén K (2016)
A Cell-Based High-Throughput Assay for Gap Junction Communication Suitable for Assessing Connexin 43-Ezrin Interaction Disruptors Using IncuCyte ZOOM
SLAS Discov, 22 (1), 77-85
DOI 10.1177/1087057116669120, PubMed 27628689
Jensenius M, Winje BA, Blomberg B, Mengshoel AT, Lippe Bv, Hannula R, Bruun JN, Knudsen PK, Rønning JO, Heldal E, Dyrhol-Riise AM (2016)
Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014
Int J Tuberc Lung Dis, 20 (6), 786-92
DOI 10.5588/ijtld.15.0895, PubMed 27155182
Jenum S, Bakken R, Dhanasekaran S, Mukherjee A, Lodha R, Singh S, Singh V, Haks MC, Ottenhoff TH, Kabra SK, Doherty TM, Ritz C, Grewal HM (2016)
BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome
Sci Rep, 6, 38841
DOI 10.1038/srep38841, PubMed 27941850
Jenum S, Dhanasekaran S, Ritz C, Macaden R, Doherty TM, Grewal HM, TB Trials Study Group (2016)
Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis: Specific Immunity in Young Children
Pediatr Infect Dis J, 35 (12), 1336-1338
DOI 10.1097/INF.0000000000001328, PubMed 27642776
Liu LL, Landskron J, Ask EH, Enqvist M, Sohlberg E, Traherne JA, Hammer Q, Goodridge JP, Larsson S, Jayaraman J, Oei VYS, Schaffer M, Taskén K, Ljunggren HG, Romagnani C, Trowsdale J, Malmberg KJ, Béziat V (2016)
Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans
Cell Rep, 15 (5), 1088-1099
DOI 10.1016/j.celrep.2016.04.005, PubMed 27117418
Midgard H, Bjøro B, Mæland A, Konopski Z, Kileng H, Damås JK, Paulsen J, Heggelund L, Sandvei PK, Ringstad JO, Karlsen LN, Stene-Johansen K, Pettersson JH, Dorenberg DH, Dalgard O (2016)
Hepatitis C reinfection after sustained virological response
J Hepatol, 64 (5), 1020-1026
DOI 10.1016/j.jhep.2016.01.001, PubMed 26780289
Moltu K, Henjum K, Oberprieler NG, Bjørnbeth BA, Taskén K (2016)
Proximal signaling responses in peripheral T cells from colorectal cancer patients are affected by high concentrations of circulating prostaglandin E₂
Hum Immunol, 78 (2), 129-137
DOI 10.1016/j.humimm.2016.10.007, PubMed 27769746
Nielsen HG, Øktedalen O, Opstad PK, Lyberg T (2016)
Plasma Cytokine Profiles in Long-Term Strenuous Exercise
J Sports Med (Hindawi Publ Corp), 2016, 7186137
DOI 10.1155/2016/7186137, PubMed 27239554
Prebensen C, Lind A, Dyrhol-Riise AM, Kvale D (2016)
Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
PLoS One, 11 (4), e0153849
DOI 10.1371/journal.pone.0153849, PubMed 27128502
Stiksrud B, Lorvik KB, Kvale D, Mollnes TE, Ueland PM, Trøseid M, Taskén K, Dyrhol-Riise AM (2016)
Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts
J Acquir Immune Defic Syndr, 73 (2), 138-48
DOI 10.1097/QAI.0000000000001080, PubMed 27632144
Tonby K, Wergeland I, Lieske NV, Kvale D, Tasken K, Dyrhol-Riise AM (2016)
The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
BMC Infect Dis, 16 (1), 599
DOI 10.1186/s12879-016-1938-8, PubMed 27776487
Uyeki TM, Mehta AK, Davey RT, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, Hoepelman AI, Gutman J, Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe (2016)
Clinical Management of Ebola Virus Disease in the United States and Europe
N Engl J Med, 374 (7), 636-46
DOI 10.1056/NEJMoa1504874, PubMed 26886522
Waagsbø B, Svardal A, Ueland T, Landrø L, Øktedalen O, Berge RK, Flo TH, Aukrust P, Damås JK (2016)
Low levels of short- and medium-chain acylcarnitines in HIV-infected patients
Eur J Clin Invest, 46 (5), 408-17
DOI 10.1111/eci.12609, PubMed 26913383
Wehbi VL, Taskén K (2016)
Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units
Front Immunol, 7, 222
DOI 10.3389/fimmu.2016.00222, PubMed 27375620
Wergeland I, Assmus J, Dyrhol-Riise AM (2016)
Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls
PLoS One, 11 (9), e0163848
DOI 10.1371/journal.pone.0163848, PubMed 27685462
Zhou DT, Nehumba D, Oktedalen O, Marange P, Kodogo V, Gomo ZA, Esterhuizen TM, Stray-Pedersen B (2016)
Changes in Lipid Profiles of HIV(+) Adults over Nine Months at a Harare HIV Clinic: A Longitudinal Study
Biochem Res Int, 2016, 3204818
DOI 10.1155/2016/3204818, PubMed 27051532

Publications 2015

Chellappa S, Hugenschmidt H, Hagness M, Line PD, Labori KJ, Wiedswang G, Taskén K, Aandahl EM (2015)
Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
Oncoimmunology, 5 (4), e1102828
DOI 10.1080/2162402X.2015.1102828, PubMed 27141387
Chellappa S, Lieske NV, Hagness M, Line PD, Taskén K, Aandahl EM (2015)
Human regulatory T cells control TCR signaling and susceptibility to suppression in CD4+ T cells
J Leukoc Biol, 100 (1), 5-16
DOI 10.1189/jlb.2HI0815-334R, PubMed 26715685
Feruglio SL, Tonby K, Kvale D, Dyrhol-Riise AM (2015)
Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
Clin Exp Immunol, 179 (3), 454-65
DOI 10.1111/cei.12468, PubMed 25313008
Gaardbo JC, Trøsied M, Stiksrud B, Midttun Ø, Ueland PM, Ullum H, Nielsen SD (2015)
Increased Tryptophan Catabolism Is Associated With Increased Frequency of CD161+Tc17/MAIT Cells and Lower CD4+ T-Cell Count in HIV-1 Infected Patients on cART After 2 Years of Follow-Up
J Acquir Immune Defic Syndr, 70 (3), 228-35
DOI 10.1097/QAI.0000000000000758, PubMed 26470032
Gerbaud P, Taskén K, Pidoux G (2015)
Spatiotemporal regulation of cAMP signaling controls the human trophoblast fusion
Front Pharmacol, 6, 202
DOI 10.3389/fphar.2015.00202, PubMed 26441659
Haabeth OA, Lorvik KB, Yagita H, Bogen B, Corthay A (2015)
Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
Oncoimmunology, 5 (1), e1039763
DOI 10.1080/2162402X.2015.1039763, PubMed 26942052
Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M et al. (2015)
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
Clin Infect Dis, 62 (5), 655-663
DOI 10.1093/cid/civ963, PubMed 26620652
Lieske NV, Tonby K, Kvale D, Dyrhol-Riise AM, Tasken K (2015)
Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
PLoS One, 10 (11), e0141903
DOI 10.1371/journal.pone.0141903, PubMed 26544592
Parente-Ribes A, Skånland SS, Bürgler S, Os A, Wang D, Bogen B, Tjønnfjord GE, Taskén K, Munthe LA (2015)
Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells
Haematologica, 101 (2), e59-62
DOI 10.3324/haematol.2015.135590, PubMed 26589914
Pidoux G, Taskén K (2015)
Anchored PKA as a gatekeeper for gap junctions
Commun Integr Biol, 8 (4), e1057361
DOI 10.1080/19420889.2015.1057361, PubMed 26478781
Prebensen C, Ueland T, Michelsen AE, Lind A, Pettersen FO, Mollnes TE, Aukrust P, Dyrhol-Riise AM, Kvale D (2015)
High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection
J Acquir Immune Defic Syndr, 69 (4), 395-402
DOI 10.1097/QAI.0000000000000617, PubMed 26115437
Raslan Z, Magwenzi S, Aburima A, Taskén K, Naseem KM (2015)
Targeting of type I protein kinase A to lipid rafts is required for platelet inhibition by the 3',5'-cyclic adenosine monophosphate-signaling pathway
J Thromb Haemost, 13 (9), 1721-34
DOI 10.1111/jth.13042, PubMed 26176741
Riise AMD (2015)
Our Voices HIV: 30 years in Norway
Tidsskr. Nor. Laegeforen., 135 (19), 1769
DOI 10.4045/tidsskr.15.0785
Santegoets SJ, Dijkgraaf EM, Battaglia A, Beckhove P, Britten CM, Gallimore A, Godkin A, Gouttefangeas C, de Gruijl TD, Koenen HJ, Scheffold A, Shevach EM, Staats J, Taskén K, Whiteside TL, Kroep JR, Welters MJ, van der Burg SH (2015)
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
Cancer Immunol Immunother, 64 (10), 1271-86
DOI 10.1007/s00262-015-1729-x, PubMed 26122357
Stiksrud B, Nowak P, Nwosu FC, Kvale D, Thalme A, Sonnerborg A, Ueland PM, Holm K, Birkeland SE, Dahm AE, Sandset PM, Rudi K, Hov JR, Dyrhol-Riise AM, Trøseid M (2015)
Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
J Acquir Immune Defic Syndr, 70 (4), 329-37
DOI 10.1097/QAI.0000000000000784, PubMed 26258571
Tonby K, Ruhwald M, Kvale D, Dyrhol-Riise AM (2015)
IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
Sci Rep, 5, 9223
DOI 10.1038/srep09223, PubMed 25783975
Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, Kvale D, Damås JK, Aukrust P, Mollnes TE, Dyrhol-Riise AM (2015)
IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy
J Infect, 70 (4), 381-91
DOI 10.1016/j.jinf.2014.12.019, PubMed 25597826

Publications 2014

Brekke K, Lind A, Holm-Hansen C, Haugen IL, Sørensen B, Sommerfelt M, Kvale D (2014)
Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial
PLoS One, 9 (11), e112556
DOI 10.1371/journal.pone.0112556, PubMed 25398137
Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F (2014)
Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient
Genome Biol, 15 (11), 490
DOI 10.1186/s13059-014-0490-3, PubMed 25418686
Ellinger B, Silber J, Prashar A, Landskron J, Weber J, Rehermann S, Müller FJ, Smith S, Wrigley S, Taskén K, Gribbon P, Labes A, Imhoff JF (2014)
A phenotypic screening approach to identify anticancer compounds derived from marine fungi
Assay Drug Dev Technol, 12 (3), 162-75
DOI 10.1089/adt.2013.564, PubMed 24735443
Halvorsen B, Smedbakken LM, Michelsen AE, Skjelland M, Bjerkeli V, Sagen EL, Taskén K, Bendz B, Gullestad L, Holm S, Biessen EA, Aukrust P (2014)
Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13
Atherosclerosis, 234 (2), 352-9
DOI 10.1016/j.atherosclerosis.2014.03.021, PubMed 24732574
Hesstvedt L, Reikvam DH, Dunlop O (2014)
Neurological melioidosis in Norway presenting with a cerebral abscess
IDCases, 2 (1), 16-8
DOI 10.1016/j.idcr.2014.11.001, PubMed 26793441
Landskron J, Helland Ø, Torgersen KM, Aandahl EM, Gjertsen BT, Bjørge L, Taskén K (2014)
Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients
Cancer Immunol Immunother, 64 (3), 337-47
DOI 10.1007/s00262-014-1636-6, PubMed 25416072
Lind A, Brekke K, Pettersen FO, Mollnes TE, Trøseid M, Kvale D (2014)
A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers
PLoS One, 9 (1), e85604
DOI 10.1371/journal.pone.0085604, PubMed 24416431
Maeland A (2014)
Antiretroviral treatment initiation
Lancet Infect Dis, 14 (12), 1175
DOI 10.1016/S1473-3099(14)70947-8, PubMed 25455976
Manner IW, Baekken M, Oektedalen O, Kvale D, Nowak P, Nielsen SD, Os I, Trøseid M (2014)
Plasma lipopolysaccharide and triglycerides are independently associated and both markers correlate with the development of metabolic syndrome in HIV infection
J Acquir Immune Defic Syndr, 65 (4), e158-61
DOI 10.1097/QAI.0000000000000055, PubMed 24577189
Mocroft A, Ryom L, Begovac J, Monforte AD, Vassilenko A, Gatell J, Florence E, Ormaasen V, Kirk O, Lundgren JD, EuroSIDA in EuroCOORD (2014)
Deteriorating renal function and clinical outcomes in HIV-positive persons
AIDS, 28 (5), 727-37
DOI 10.1097/QAD.0000000000000134, PubMed 24983543
Olson AD, Guiguet M, Zangerle R, Gill J, Perez-Hoyos S, Lodi S, Ghosn J, Dorrucci M, Johnson A, Sannes M, Moreno S, Porter K, for CASCADE Collaboration in EuroCoord (2014)
Evaluation of rapid progressors in HIV infection as an extreme phenotype
J Acquir Immune Defic Syndr, 67 (1), 15-21
DOI 10.1097/QAI.0000000000000240, PubMed 24872130
Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
J Acquir Immune Defic Syndr, 67 (4), 370-4
DOI 10.1097/QAI.0000000000000339, PubMed 25226210
Pettersen PS, Brox IK, Naman E, Bruun JN, Dyrhol-Riise AM, Trøseid M, Johannessen A (2014)
Antiretroviral treatment failure predicts mortality in rural Tanzania
Int J STD AIDS, 26 (9), 633-9
DOI 10.1177/0956462414548460, PubMed 25122578
Pidoux G, Gerbaud P, Dompierre J, Lygren B, Solstad T, Evain-Brion D, Taskén K (2014)
A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusion
J Cell Sci, 127 (Pt 19), 4172-85
DOI 10.1242/jcs.149609, PubMed 25052094
Pullar ND, Steinum H, Tonby K, Heggelund L, Leiva RA, Ofstad R, Bruun JN, Dyrhol-Riise AM (2014)
Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway
Int J Tuberc Lung Dis, 18 (2), 180-7
DOI 10.5588/ijtld.13.0276, PubMed 24429310
Skånland SS, Moltu K, Berge T, Aandahl EM, Taskén K (2014)
T-cell co-stimulation through the CD2 and CD28 co-receptors induces distinct signalling responses
Biochem J, 460 (3), 399-410
DOI 10.1042/BJ20140040, PubMed 24665965
Spurgeon BE, Aburima A, Oberprieler NG, Taskén K, Naseem KM (2014)
Multiplexed phosphospecific flow cytometry enables large-scale signaling profiling and drug screening in blood platelets
J Thromb Haemost, 12 (10), 1733-43
DOI 10.1111/jth.12670, PubMed 25056834
Trøseid M, Ditlevsen S, Hvid T, Gerstoft J, Grøndahl T, Pedersen BK, Nielsen SD, Lindegaard B (2014)
Reduced trunk fat and triglycerides after strength training are associated with reduced LPS levels in HIV-infected individuals
J Acquir Immune Defic Syndr, 66 (2), e52-4
DOI 10.1097/QAI.0000000000000132, PubMed 24608893
Trøseid M, Manner IW, Pedersen KK, Haissman JM, Kvale D, Nielsen SD (2014)
Microbial translocation and cardiometabolic risk factors in HIV infection
AIDS Res Hum Retroviruses, 30 (6), 514-22
DOI 10.1089/aid.2013.0280, PubMed 24521167
Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, Karlsen TH, Aukrust P, Gullestad L, Berge RK, Yndestad A (2014)
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure
J Intern Med, 277 (6), 717-26
DOI 10.1111/joim.12328, PubMed 25382824
Wæhre T, Maagard A, Tappe D, Cadar D, Schmidt-Chanasit J (2014)
Zika virus infection after travel to Tahiti, December 2013
Emerg Infect Dis, 20 (8), 1412-4
DOI 10.3201/eid2008.140302, PubMed 25062427

Publications 2013

Andersson LM, Vesterbacka J, Blaxhult A, Flamholc L, Nilsson S, Ormaasen V, Sönnerborg A, Gisslén M (2013)
Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: an open-label randomized controlled trial
Scand J Infect Dis, 45 (7), 543-51
DOI 10.3109/00365548.2012.756985, PubMed 23294034
Cornez I, Joel M, Taskén K, Langmoen IA, Glover JC, Berge T (2013)
EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry
J Neurooncol, 112 (1), 49-57
DOI 10.1007/s11060-012-1035-9, PubMed 23299461
Drozd F, Skeie LG, Kraft P, Kvale D (2013)
A web-based intervention trial for depressive symptoms and subjective well-being in patients with chronic HIV infection
AIDS Care, 26 (9), 1080-9
DOI 10.1080/09540121.2013.869541, PubMed 24359563
Feruglio SL, Trøseid M, Damås JK, Kvale D, Dyrhol-Riise AM (2013)
Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses
PLoS One, 8 (7), e69896
DOI 10.1371/journal.pone.0069896, PubMed 23875007
Haugaard AK, Lund TT, Birch C, Rönsholt F, Trøseid M, Ullum H, Gerstoft J, Johansson PI, Nielsen SD, Ostrowski SR (2013)
Discrepant coagulation profile in HIV infection: elevated D-dimer but impaired platelet aggregation and clot initiation
AIDS, 27 (17), 2749-58
DOI 10.1097/01.aids.0000432462.21723.ed, PubMed 23842126
Landskron J, Taskén K (2013)
CD147 in regulatory T cells
Cell Immunol, 282 (1), 17-20
DOI 10.1016/j.cellimm.2013.04.008, PubMed 23665204
Lind A, Brekke K, Sommerfelt M, Holmberg JO, Aass HC, Baksaas I, Sørensen B, Dyrhol-Riise AM, Kvale D (2013)
Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms
Vaccine, 31 (41), 4611-8
DOI 10.1016/j.vaccine.2013.07.037, PubMed 23906886
Lone AM, Taskén K (2013)
Proinflammatory and immunoregulatory roles of eicosanoids in T cells
Front Immunol, 4, 130
DOI 10.3389/fimmu.2013.00130, PubMed 23760108
MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BÅ, Jonsrud K, Lundgren B, Mellegård H, Møller-Stray J, Rønning K, Vestrheim DF, Vold L (2013)
Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013
Euro Surveill, 18 (45), 20630
DOI 10.2807/1560-7917.es2013.18.45.20630, PubMed 24229788
MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BA, Jonsrud K, Lundgren B, Mellegard H, Moller-Stray J, Ronning K, Vestrheim DF, Vold L (2013)
Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013
Eurosurveillance, 18 (45), 2-5
Madec Y, Boufassa F, Porter K, Prins M, Sabin C, d'Arminio Monforte A, Amornkul P, Bartmeyer B, Sannes M, Venet A, Lambotte O, Meyer L, CASCADE Collaboration in Eurocoord (2013)
Natural history of HIV-control since seroconversion
AIDS, 27 (15), 2451-60
DOI 10.1097/01.aids.0000431945.72365.01, PubMed 23912979
Manner IW, Baekken M, Kvale D, Oektedalen O, Pedersen M, Nielsen SD, Nowak P, Os I, Trøseid M (2013)
Markers of microbial translocation predict hypertension in HIV-infected individuals
HIV Med, 14 (6), 354-61
DOI 10.1111/hiv.12015, PubMed 23332095
Pedersen KK, Pedersen M, Trøseid M, Gaardbo JC, Lund TT, Thomsen C, Gerstoft J, Kvale D, Nielsen SD (2013)
Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction
J Acquir Immune Defic Syndr, 64 (5), 425-33
DOI 10.1097/QAI.0b013e31829f919d, PubMed 23797689
Rogne M, Taskén K (2013)
Cell signalling analyses in the functional genomics era
N Biotechnol, 30 (3), 333-8
DOI 10.1016/j.nbt.2013.01.003, PubMed 23369868
Singh M, Singh P, Vaira D, Torheim EA, Rahmouni S, Taskén K, Moutschen M (2013)
The RIAD peptidomimetic inhibits HIV-1 replication in humanized NSG mice
Eur J Clin Invest, 44 (2), 146-52
DOI 10.1111/eci.12200, PubMed 24283208
Størvold GL, Landskron J, Strozynski M, Arntzen MØ, Koehler CJ, Kalland ME, Taskén K, Thiede B (2013)
Quantitative profiling of tyrosine phosphorylation revealed changes in the activity of the T cell receptor signaling pathway upon cisplatin-induced apoptosis
J Proteomics, 91, 344-57
DOI 10.1016/j.jprot.2013.07.019, PubMed 23933134
Ushakova A, Pettersen FO, Mæland A, Lindqvist BH, Kvale D (2013)
Bayesian estimation of HIV-1 dynamics in vivo
Math Med Biol, 32 (1), 38-55
DOI 10.1093/imammb/dqt018, PubMed 24078026
Vang T, Landskron J, Viken MK, Oberprieler N, Torgersen KM, Mustelin T, Tasken K, Tautz L, Rickert RC, Lie BA (2013)
The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses
Hum Immunol, 74 (5), 574-85
DOI 10.1016/j.humimm.2012.12.017, PubMed 23333624

Publications 2012

Brantsæter AB (2012)
[Malaria treatment--herbal therapy in new clothes]
Tidsskr Nor Laegeforen, 132 (6), 614
DOI 10.4045/tidsskr.12.0238, PubMed 22456126
Brantsæter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, Rollag H, Bruun JN, Kvale D (2012)
Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
Int J Infect Dis, 16 (12), e879-85
DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419
Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
J Acquir Immune Defic Syndr, 59 (2), e24-5
DOI 10.1097/QAI.0b013e31823f35a7, PubMed 22245717
Damås JK, Øktedalen O, Ueland T, Landrø L, Barstad J, Müller F, Frøland SS, Flo TH, Aukrust P (2012)
Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
Clin Exp Immunol, 167 (3), 492-8
DOI 10.1111/j.1365-2249.2011.04524.x, PubMed 22288592
De Iaco G, Puro V, Fusco FM, Schilling S, Maltezou HC, Brouqui P, Gottschalk R, Bannister B, Brodt HR, Siikamaki H, Perronne C, Brantsæter AB, Fjellet AL, Ippolito G, European Network for Highly Infectious Diseases Working Group (2012)
Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries
Infect Control Hosp Epidemiol, 33 (10), 1008-16
DOI 10.1086/667729, PubMed 22961020
Kalland ME, Solheim SA, Skånland SS, Taskén K, Berge T (2012)
Modulation of proximal signaling in normal and transformed B cells by transmembrane adapter Cbp/PAG
Exp Cell Res, 318 (14), 1611-9
DOI 10.1016/j.yexcr.2012.05.014, PubMed 22659621
Lind A, Sommerfelt M, Holmberg JO, Baksaas I, Sørensen B, Kvale D (2012)
Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
Scand J Infect Dis, 44 (8), 566-72
DOI 10.3109/00365548.2011.653581, PubMed 22339485
Lodi S, Meyer L, Kelleher AD, Rosinska M, Ghosn J, Sannes M, Porter K (2012)
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion
Arch Intern Med, 172 (16), 1252-5
DOI 10.1001/archinternmed.2012.2719, PubMed 22826124
Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I (2012)
Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals
J Clin Hypertens (Greenwich), 15 (2), 101-6
DOI 10.1111/jch.12029, PubMed 23339727
Nowak P, Abdurahman S, Lindkvist A, Troseid M, Sönnerborg A (2012)
Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection
Int J Microbiol, 2012, 263836
DOI 10.1155/2012/263836, PubMed 22719767
Nowak P, Nystrom J, Troseid M (2012)
High levels of HMGB1 in plasma may be due to ex vivo cell necrosis
Anticancer Res, 32 (9), 4067-9
PubMed 22993362
Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
Arterioscler Thromb Vasc Biol, 33 (2), e47-55
DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017
Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V (2012)
Infectious encephalitis: a description of a Norwegian cohort
Scand J Infect Dis, 45 (3), 179-85
DOI 10.3109/00365548.2012.719634, PubMed 23113672
Rekić D, Röshammar D, Bergstrand M, Tarning J, Calcagno A, D'Avolio A, Ormaasen V, Vigan M, Barrail-Tran A, Ashton M, Gisslén M, Äbelö A (2012)
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
AAPS J, 15 (2), 308-15
DOI 10.1208/s12248-012-9440-8, PubMed 23224752
Scott JD, Dessauer CW, Taskén K (2012)
Creating order from chaos: cellular regulation by kinase anchoring
Annu Rev Pharmacol Toxicol, 53, 187-210
DOI 10.1146/annurev-pharmtox-011112-140204, PubMed 23043438
Trøseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen KK, Kanda T, Funaoka H, Damås JK, Kvale D (2012)
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
Innate Immun, 19 (3), 290-7
DOI 10.1177/1753425912461042, PubMed 23070967
Wessman M, Westling K, Aho I, Quist-Paulsen E, Wæhre T, Rolfhamre L, Weis N, Katzenstein TL (2012)
Major differences in assisted reproductive treatments offered to HIV-1 infected patients in the Nordic countries
Scand J Infect Dis, 44 (5), 402-4
DOI 10.3109/00365548.2011.649491, PubMed 22292615

Publications 2011

Berdal JE, Mollnes TE, Wæhre T, Olstad OK, Halvorsen B, Ueland T, Laake JH, Furuseth MT, Maagaard A, Kjekshus H, Aukrust P, Jonassen CM (2011)
Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
J Infect, 63 (4), 308-16
DOI 10.1016/j.jinf.2011.07.004, PubMed 21781987
Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
BMC Infect Dis, 11, 75
DOI 10.1186/1471-2334-11-75, PubMed 21435254
Brantsæter AB (2011)
[Did vaccines and hygiene recommendations affect the pandemic?]
Tidsskr Nor Laegeforen, 131 (7), 662
DOI 10.4045/tidsskr.11.0318, PubMed 21494288
Corthay A, Lorvik KB, Bogen B (2011)
Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer
Scand J Immunol, 73 (6), 527-30
DOI 10.1111/j.1365-3083.2011.02558.x, PubMed 21388431
Hesstvedt L, Wilhelmsen M, Mengshoel AT, Dyrhol-Riise AM (2011)
Two Norwegian patients with melioidosis presenting with bacteraemia and splenic and prostatic abscesses
J Travel Med, 18 (6), 418-21
DOI 10.1111/j.1708-8305.2011.00550.x, PubMed 22017720
Kivuyo SL, Johannessen A, Trøseid M, Kasubi MJ, Gundersen SG, Naman E, Mushi D, Ngowi BJ, Mfinanga GS, Bruun JN (2011)
p24 antigen detection on dried blood spots is a feasible and reliable test for infant HIV infection in rural Tanzania
Int J STD AIDS, 22 (12), 719-21
DOI 10.1258/ijsa.2009.009382, PubMed 22174052
Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2011)
Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection
APMIS, 120 (3), 204-9
DOI 10.1111/j.1600-0463.2011.02843.x, PubMed 22339677
Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
J Virol, 85 (13), 6557-66
DOI 10.1128/JVI.00073-11, PubMed 21490090
Rekić D, Clewe O, Röshammar D, Flamholc L, Sönnerborg A, Ormaasen V, Gisslén M, Abelö A, Ashton M (2011)
Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy
AAPS J, 13 (4), 598-605
DOI 10.1208/s12248-011-9299-0, PubMed 21913053
Röshammar D, Simonsson US, Ekvall H, Flamholc L, Ormaasen V, Vesterbacka J, Wallmark E, Ashton M, Gisslén M (2011)
Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients
J Pharmacokinet Pharmacodyn, 38 (6), 727-42
DOI 10.1007/s10928-011-9217-1, PubMed 21964996
Trøseid M (2011)
[The fight against HIV--two scenarios]
Tidsskr Nor Laegeforen, 131 (23), 2331
DOI 10.4045/tidsskr.11.1213, PubMed 22139097
Trøseid M, Sönnerborg A, Nowak P (2011)
High mobility group box protein-1 in HIV-1 infection
Curr HIV Res, 9 (1), 6-10
DOI 10.2174/157016211794582632, PubMed 21198433
van der Helm JJ, Prins M, del Amo J, Bucher HC, Chêne G, Dorrucci M, Gill J, Hamouda O, Sannes M, Porter K, Geskus RB, CASCADE Collaboration (2011)
The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007
AIDS, 25 (8), 1083-91
DOI 10.1097/QAD.0b013e3283471cce, PubMed 21537114

Publications 2010

Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
J Acquir Immune Defic Syndr, 53 (3), 419-20
DOI 10.1097/QAI.0b013e3181ba4101, PubMed 20190590
Bratholm C, Johannessen A, Naman E, Gundersen SG, Kivuyo SL, Holberg-Petersen M, Ormaasen V, Bruun JN (2010)
Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital
J Antimicrob Chemother, 65 (9), 1996-2000
DOI 10.1093/jac/dkq234, PubMed 20576637
Edén A, Andersson LM, Andersson O, Flamholc L, Josephson F, Nilsson S, Ormaasen V, Svedhem V, Säll C, Sönnerborg A, Tunbäck P, Gisslén M (2010)
Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients
AIDS Res Hum Retroviruses, 26 (5), 533-40
DOI 10.1089/aid.2009.0177, PubMed 20455766
Grydeland H, Walhovd KB, Westlye LT, Due-Tønnessen P, Ormaasen V, Sundseth Ø, Fjell AM (2010)
Amnesia following herpes simplex encephalitis: diffusion-tensor imaging uncovers reduced integrity of normal-appearing white matter
Radiology, 257 (3), 774-81
DOI 10.1148/radiol.10100179, PubMed 20935078
Jenum PA, Flesland Ø, Blystad H, Vik IS, Hervig T, Maeland A, Saeter G (2010)
[Syphilis and blood transfusion]
Tidsskr Nor Laegeforen, 130 (8), 839-41
DOI 10.4045/tidsskr.08.0188, PubMed 20418930
Johannessen A, Holberg-Petersen M, Lövgaarden G, Naman E, Ormaasen V, Matee MI, Gundersen SG, Bruun JN (2010)
HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania
Antivir Ther, 15 (7), 1003-9
DOI 10.3851/IMP1660, PubMed 21041915
Kran AM, Jonassen TO, Sommerfelt MA, Løvgården G, Sørensen B, Kvale D (2010)
Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
AIDS, 24 (17), 2609-18
DOI 10.1097/QAD.0b013e32833e502b, PubMed 20935558
Pettersen FO, Taskén K, Kvale D (2010)
Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection
Clin Exp Immunol, 161 (2), 315-23
DOI 10.1111/j.1365-2249.2010.04179.x, PubMed 20491784

Publications 2009

Brantsaeter AB (2009)
[An underestimated throat bacteria]
Tidsskr Nor Laegeforen, 129 (17), 1756
DOI 10.4045/tidsskr.09.0788, PubMed 19756058
Corthay A, Lundin KU, Lorvik KB, Hofgaard PO, Bogen B (2009)
Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells
Cancer Res, 69 (14), 5901-7
DOI 10.1158/0008-5472.CAN-08-4816, PubMed 19567679
Hauge SH, Dudman SG, Borgen K, Hungnes O, Brantsaeter A, Iversen B, Aavitsland P (2009)
[Disease caused by the new influenza A(H1N1) virus]
Tidsskr Nor Laegeforen, 129 (17), 1736-9
DOI 10.4045/tidsskr.09.0748, PubMed 19756053
Josephson F, Andersson MC, Flamholc L, Gisslén M, Hagberg L, Ormaasen V, Sönnerborg A, Vesterbacka J, Böttiger Y (2009)
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
Eur J Clin Pharmacol, 66 (4), 349-57
DOI 10.1007/s00228-009-0763-z, PubMed 19967342
Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
J Clin Microbiol, 47 (7), 2170-4
DOI 10.1128/JCM.00519-09, PubMed 19420166
Maagaard A, Kvale D (2009)
Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity
Scand J Infect Dis, 41 (11-12), 808-17
DOI 10.3109/00365540903186181, PubMed 19922062
Maagaard A, Kvale D (2009)
Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
J Antimicrob Chemother, 64 (5), 901-9
DOI 10.1093/jac/dkp316, PubMed 19740910
Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hoepelman I, Horban A, Korn K, Kücherer C, Leitner T et al. (2009)
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
Retrovirology, 6, 49
DOI 10.1186/1742-4690-6-49, PubMed 19457244
Sandanger Ø, Ryan L, Bohnhorst J, Iversen AC, Husebye H, Halaas Ø, Landrø L, Aukrust P, Frøland SS, Elson G, Visintin A, Øktedalen O, Damås JK, Sundan A, Golenbock D, Espevik T (2009)
IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients
J Immunol, 182 (1), 588-95
DOI 10.4049/jimmunol.182.1.588, PubMed 19109192
Skeie L, Bugge H, Negaard A, Bergersen BM (2009)
Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study
HIV Med, 11 (3), 170-7
DOI 10.1111/j.1468-1293.2009.00761.x, PubMed 19780861
Torheim EA, Ndhlovu LC, Pettersen FO, Larsen TL, Jha AR, Torgersen KM, Kvale D, Nixon DF, Taskén K, Aandahl EM (2009)
Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population
Eur J Immunol, 39 (5), 1280-7
DOI 10.1002/eji.200839002, PubMed 19384871

Publications 2008

Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K, CASCADE Collaboration (2008)
Changes in the risk of death after HIV seroconversion compared with mortality in the general population
JAMA, 300 (1), 51-9
DOI 10.1001/jama.300.1.51, PubMed 18594040
Bjark P, Ormaasen V, Skjelmerud T (2008)
[Treatment of erythema migrans]
Tidsskr Nor Laegeforen, 128 (24), 2844
PubMed 19092956
Brantsaeter AB (2008)
[Action against tuberculosis--all has its time]
Tidsskr Nor Laegeforen, 128 (24), 2817
PubMed 19092946
Holm M, Pettersen FO, Kvale D (2008)
PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples
Curr HIV Res, 6 (1), 49-58
DOI 10.2174/157016208783571955, PubMed 18288975
Josephson F, Bertilsson L, Böttiger Y, Flamholc L, Gisslén M, Ormaasen V, Sönnerborg A, Diczfalusy U (2008)
CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels
Eur J Clin Pharmacol, 64 (8), 775-81
DOI 10.1007/s00228-008-0492-8, PubMed 18458892
Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D (2008)
Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment
J Infect Dis, 198 (10), 1474-81
DOI 10.1086/592713, PubMed 18851688

Publications 2007

Brantsaeter AB, Holberg-Petersen M, Jeansson S, Goplen AK, Bruun JN (2007)
CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection - a retrospective autopsy based study
BMC Infect Dis, 7, 127
DOI 10.1186/1471-2334-7-127, PubMed 17986346
Bugge H, Negaard A, Skeie L, Bergersen B (2007)
Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients
HIV Med, 8 (8), 475-82
DOI 10.1111/j.1468-1293.2007.00494.x, PubMed 17944679
Jensenius M, Berild D, Ormaasen V, Maehlen J, Lindegren G, Falk KI (2007)
Fatal subarachnoidal haemorrhage in a Norwegian traveller with dengue virus infection
Scand J Infect Dis, 39 (3), 272-4
DOI 10.1080/00365540600891307, PubMed 17366065
Jensenius M, Maeland A, Brubakk O (2007)
Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics
Travel Med Infect Dis, 6 (1-2), 45-7
DOI 10.1016/j.tmaid.2007.09.043, PubMed 18342274
Maagaard A, Holberg-Petersen M, Torjesen PA, Bruun JN, Kvale D (2007)
Insulin resistance is affected by increased levels of plasma lactate but not mitochondrial alterations in skeletal muscle in NRTI-exposed HIV-infected patients
HIV Clin Trials, 8 (5), 345-53
DOI 10.1310/hct0805-345, PubMed 17956836

Publications 2006

Bergersen BM (2006)
Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy
Drugs, 66 (15), 1971-87
DOI 10.2165/00003495-200666150-00006, PubMed 17100407
Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
Scand J Infect Dis, 38 (8), 682-9
DOI 10.1080/00365540500361302, PubMed 16857615
Brantsaeter AB (2006)
[Tularemia]
Tidsskr Nor Laegeforen, 126 (8), 1034
PubMed 16619059
Bruun JN, Skeie L, Maeland A, Dudman SG, Sannes M, Ormaasen V (2006)
[HIV/AIDS--from lethal syndrome to chronic disease]
Tidsskr Nor Laegeforen, 126 (23), 3121-4
PubMed 17160119
Kran AM, Kvale D (2006)
[Immunopathogenesis and therapeutic immunization in HIV-infection]
Tidsskr Nor Laegeforen, 126 (23), 3112-6
PubMed 17160117
Kran AM, Sørensen B, Sommerfelt MA, Nyhus J, Baksaas I, Kvale D (2006)
Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
AIDS, 20 (4), 627-30
DOI 10.1097/01.aids.0000210620.75707.ac, PubMed 16470131
Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K (2006)
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
AIDS, 20 (6), 813-20
DOI 10.1097/01.aids.0000218544.54586.f1, PubMed 16549964
Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, Bruun JN (2006)
Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients
Antivir Ther, 11 (5), 601-8
PubMed 16964828
Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN (2006)
Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients
HIV Med, 7 (1), 53-8
DOI 10.1111/j.1468-1293.2005.00336.x, PubMed 16313293
Nygård K, Brantsaeter A, Feruglio S, Ravn J, Dotevall L, Hasle G, Myrvang B (2006)
[Histoplasmosis among travellers to Central America]
Tidsskr Nor Laegeforen, 126 (21), 2838-42
PubMed 17086244
Skeie L, Maeland A (2006)
Can efavirenz be taken in the morning?
Scand J Infect Dis, 38 (11-12), 1089-91
DOI 10.1080/00365540600794386, PubMed 17148083
van de Vijver DA, Wensing AM, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L et al. (2006)
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
J Acquir Immune Defic Syndr, 41 (3), 352-60
DOI 10.1097/01.qai.0000209899.05126.e4, PubMed 16540937

Publications 2005

Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE (2005)
Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
Haematologica, 90 (1), 86-93
PubMed 15642674
Bergersen BM, Sandvik L, Ellingsen I, Bruun JN (2005)
Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive
HIV Med, 6 (4), 260-7
DOI 10.1111/j.1468-1293.2005.00305.x, PubMed 16011531
Blystad H, Brantsaeter AB, Lovoll Ø (2005)
Outbreak of community-acquired legionnaires disease in southeast Norway, May 2005
Euro Surveill, 10 (5), E050526.1
PubMed 16770016
Farah MG, Tverdal A, Steen TW, Heldal E, Brantsaeter AB, Bjune G (2005)
Treatment outcome of new culture positive pulmonary tuberculosis in Norway
BMC Public Health, 5, 14
DOI 10.1186/1471-2458-5-14, PubMed 15698472
Kran AM, Sommerfelt MA, Sørensen B, Nyhus J, Baksaas I, Bruun JN, Kvale D (2005)
Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization
Vaccine, 23 (31), 4011-5
DOI 10.1016/j.vaccine.2005.03.010, PubMed 15963359
Kvale D, Kran AM, Sommerfelt MA, Nyhus J, Baksaas I, Bruun JN, Sørensen B (2005)
Divergent in vitro and in vivo correlates of HIV-specific T-cell responses during onset of HIV viraemia
AIDS, 19 (6), 563-7
DOI 10.1097/01.aids.0000163932.76531.c6, PubMed 15802974
Nygård K, Brantsaeter AB, Mehl R (2005)
Disseminated and chronic Lyme borreliosis in Norway, 1995 - 2004
Euro Surveill, 10 (10), 235-8
PubMed 16282646
Nyhus J, Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2005)
Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
Vaccine, 24 (10), 1543-50
DOI 10.1016/j.vaccine.2005.10.012, PubMed 16289707
Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L et al. (2005)
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
J Infect Dis, 192 (6), 958-66
DOI 10.1086/432916, PubMed 16107947

Publications 2004

Cook CC, Brekke K (2004)
Productivity preservation through hydraulic propped fractures in the Eldfisk North Sea chalk field
SPE Reserv. Eval. Eng., 7 (2), 105-114
DOI 10.2118/88031-PA
Kran AM, Sørensen B, Nyhus J, Sommerfelt MA, Baksaas I, Bruun JN, Kvale D (2004)
HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
AIDS, 18 (14), 1875-83
DOI 10.1097/00002030-200409240-00003, PubMed 15353973
Lugada ES, Mermin J, Asjo B, Kaharuza F, Downing R, Langeland N, Ormaasen V, Bruun J, Awor AC, Ulvestad E (2004)
Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway
Scand J Immunol, 59 (2), 203-8
DOI 10.1111/j.0300-9475.2004.01376.x, PubMed 14871298
Nilssen DE, Øktedalen O, Brandtzaeg P (2004)
Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy
Gut, 53 (4), 487-93
DOI 10.1136/gut.2003.027854, PubMed 15016741

Publications 2003

Maeland A, Ronnestad I, Waagbo R (2003)
Folate in eggs and developing larvae of Atlantic halibut, Hippoglossus hippoglossus L.
Aquac. Nutr., 9 (3), 185-188
DOI 10.1046/j.1365-2095.2003.00242.x

Publications 2002

Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Pezzotti P, Rezza G, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O et al. (2002)
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks
Int J Epidemiol, 31 (5), 951-8
DOI 10.1093/ije/31.5.951, PubMed 12435766
Bjøro K, Bell H, Hellum KB, Skaug K, Raknerud N, Sandvei P, Døskeland B, Maeland A, Lund-Tønnesen S, Myrvang B (2002)
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study
Scand J Gastroenterol, 37 (2), 226-32
DOI 10.1080/003655202753416920, PubMed 11843062
Bruun JN, Maeland A (2002)
[Mother-to-child transmission of HIV]
Tidsskr Nor Laegeforen, 122 (11), 1143; author reply 1143
PubMed 12043061
Dunlop O, Bjørklund R, Bruun JN, Evensen R, Goplen AK, Liestøl K, Sannes M, Maehlen J, Myrvang B (2002)
Early psychomotor slowing predicts the development of HIV dementia and autopsy-verified HIV encephalitis
Acta Neurol Scand, 105 (4), 270-5
DOI 10.1034/j.1600-0404.2002.9o188.x, PubMed 12004769
Maagaard A, Oktedalen O (2002)
Psoas abscess diagnosed at a Northern university hospital
Scand J Infect Dis, 34 (11), 848-51
DOI 10.1080/0036554021000026940, PubMed 12578159
Miller V, Phillips AN, Clotet B, Mocroft A, Ledergerber B, Kirk O, Ormaasen V, Gargalianos-Kakolyris P, Vella S, Lundgren JD (2002)
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts
J Infect Dis, 186 (2), 189-97
DOI 10.1086/341466, PubMed 12134254
Mørch K, Feruglio SL, Ormaasen V, Bruun JN (2002)
[Severe falciparum malaria treated with exchange transfusion]
Tidsskr Nor Laegeforen, 122 (10), 999-1001
PubMed 12082710
Rollag H, Sagedal S, Kristiansen KI, Kvale D, Holter E, Degré M, Nordal KP (2002)
Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
Clin Microbiol Infect, 8 (7), 431-4
DOI 10.1046/j.1469-0691.2002.00449.x, PubMed 12199854
Røttingen JA, Feruglio SL, Aasland OG, Fugelli P (2002)
[Local and global environmental medicine--assessment by Norwegian physicians]
Tidsskr Nor Laegeforen, 122 (13), 1285-9
PubMed 12098923

Publications 2001

Oktedalen O, Solberg EE, Haugen AH, Opstad PK (2001)
The influence of physical and mental training on plasma beta-endorphin level and pain perception after intensive physical exercise
Stress Health, 17 (2), 121-127
DOI 10.1002/smi.892
Ormaasen V, Brantsaeter AB, Moen EW (2001)
[Tick-borne encephalitis in Norway]
Tidsskr Nor Laegeforen, 121 (7), 807-9
PubMed 11301704
Ormaasen V, Maeland A (2001)
[Tuberculosis among HIV-infected persons in Norway]
Tidsskr Nor Laegeforen, 121 (29), 3425-30
PubMed 11826791
Svendsen J, Ormaasen V, von der Lippe E, Jacobsen D (2001)
[Two cases of pneumococcal pericarditis]
Tidsskr Nor Laegeforen, 121 (15), 1801-3
PubMed 11464685

Publications 2000

Bøyum A, Tennfjord VA, Gran C, Løvhaug D, Oktedalen O, Brandtzaeg P (2000)
Bioactive cytidine deaminase, an inhibitor of granulocyte-macrophage colony-forming cells, is massively released in fulminant meningococcal sepsis
J Infect Dis, 182 (6), 1784-7
DOI 10.1086/317596, PubMed 11069255
Dyrhol-Riise AM, Brantsaeter AB, Dunlop O, Baklien K, Skar AG, Asjö B, Bruun JN, Røsok BI (2000)
Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals
Scand J Immunol, 51 (2), 195-201
DOI 10.1046/j.1365-3083.2000.00659.x, PubMed 10652164
Maeland A, Ronnestad I, Fyhn HJ, Berg L, Waagbo R (2000)
Water-soluble vitamins in natural plankton (copepods) during two consecutive spring blooms compared to vitamins in Artemia franciscana nauplii and metanauplii
Mar. Biol., 136 (5), 765-772
DOI 10.1007/s002270000280
Olsen AI, Maeland A, Waagbo R, Olsen Y (2000)
Effect of algal addition on stability of fatty acids and some water-soluble vitamins in juvenile Artemia franciscana
Aquac. Nutr., 6 (4), 263-273
DOI 10.1046/j.1365-2095.2000.00157.x
Sindre H, Haraldsen G, Beck S, Hestdal K, Kvale D, Brandtzaeg P, Degré M, Rollag H (2000)
Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
Scand J Immunol, 51 (4), 354-60
DOI 10.1046/j.1365-3083.2000.00676.x, PubMed 10736107

Publications 1999

Bell H, Hellum K, Harthug S, Myrvang B, Ritland S, Maeland A, von der Lippe B, Bjøro K, Skaug K, Gutigard BG, Raknerud N, Simmonds P (1999)
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group
Scand J Gastroenterol, 34 (2), 194-8
DOI 10.1080/00365529950173087, PubMed 10192200
Maeland A, Rosenlund G, Stoss J, Waagbo R (1999)
Weaning of Atlantic halibut Hippoglossus hippoglossus L. using formulated diets with various levels of ascorbic acid
Aquac. Nutr., 5 (3), 211-219
Maeland A, Sandnes K (1999)
Determination of biotin in low-temperature fish-meal processed from different species by means of a microbiological method using Lactobacillus plantarum as test organism
J. Sci. Food Agric., 79 (10), 1298-1300
Mugnaini EN, Haaheim LL, Sannes M, Brinchmann JE (1999)
In vivo expansion coincident with excessive in vitro cell death within the memory subset of CD8+ T cells in HIV type 1 infection
AIDS Res Hum Retroviruses, 15 (3), 265-72
DOI 10.1089/088922299311448, PubMed 10052757
Mugnaini EN, Syversen AM, Sannes M, Freng A, Brinchmann JE (1999)
Normal CD4 T-cell receptor repertoire in tonsillar tissue despite perturbed repertoire in peripheral blood in HIV-1 infected individuals
AIDS, 13 (18), 2507-13
DOI 10.1097/00002030-199912240-00003, PubMed 10630519

Publications 1998

Brantsaeter AB, Hoel T, Kristianslund TI, Maeland A (1998)
[Tularemia after tick bite in Vestfold]
Tidsskr Nor Laegeforen, 118 (8), 1191-3
PubMed 9567695
Jarvis LM, Bell H, Simmonds P, Hawkins A, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K (1998)
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group
Scand J Gastroenterol, 33 (2), 195-200
DOI 10.1080/00365529850166941, PubMed 9517532
Maeland A, Waagbo R (1998)
Examination of the qualitative ability of some cold water marine teleosts to synthesise ascorbic acid
Comp. Biochem. Physiol. A-Mol. Integr. Physiol., 121 (3), 249-255
DOI 10.1016/S1095-6433(98)10125-3
Mugnaini EN, Spurkland A, Egeland T, Sannes M, Brinchmann JE (1998)
Demonstration of identical expanded clones within both CD8+CD28+ and CD8+CD28- T cell subsets in HIV type 1-infected individuals
Eur J Immunol, 28 (5), 1738-42
DOI 10.1002/(sici)1521-4141(199805)28:05<1738::aid-immu1738>3.0.co;2-s, PubMed 9603481
Nilssen DE, Oktedalen O, Lygren I, Opstad PK, Brandtzaeg P (1998)
Intestinal IgA- and IgM-producing cells are not decreased in marathon runners
Int J Sports Med, 19 (6), 425-31
DOI 10.1055/s-2007-971940, PubMed 9774211

Publications 1997

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Gutigard BG, Skjaerven R, Prescott LE, Simmonds P (1997)
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group
Scand J Infect Dis, 29 (1), 17-22
DOI 10.3109/00365549709008658, PubMed 9112292
Jensenius M, Espinoza R, Hoel T, Oktedalen O, Heger B, Skar AG, Grinde B, Skaug K, Berild D (1997)
[An outbreak of hepatitis A among intravenous drug addicts in Oslo 1995-96]
Tidsskr Nor Laegeforen, 117 (7), 935-40
PubMed 9103002
Jensenius M, Maeland A, Kvale D, Farstad IN, Vene S, Bruu AL (1997)
[Q-fever imported into Norway]
Tidsskr Nor Laegeforen, 117 (27), 3937-40
PubMed 9441420
Jensenius M, Maeland A, Vene S (1997)
[Endemic typhus imported to Norway]
Tidsskr Nor Laegeforen, 117 (17), 2447-9
PubMed 9265302
Maeland A (1997)
[Screening of pregnant women for toxoplasma infection]
Tidsskr Nor Laegeforen, 117 (8), 1184-5
PubMed 9148496
Nordøy I, Krarup HB, Bell H, Christensen PB, Elgjo K, von der Lippe B, De Muckadell OS, Maeland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E (1997)
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
Scand J Gastroenterol, 32 (12), 1256-60
DOI 10.3109/00365529709028156, PubMed 9438325

Publications 1996

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Prescott L, Simmonds P (1996)
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group
Scand J Infect Dis, 28 (4), 357-9
DOI 10.3109/00365549609037919, PubMed 8893398
Dunlop O, Rootwelt V, Sannes M, Goplen AK, Abdelnoor M, Skaug K, Baklien K, Skar A, Melby K, Myrvang B, Bruun JN (1996)
Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis
Scand J Infect Dis, 28 (1), 71-3
DOI 10.3109/00365549609027153, PubMed 9122637
Nilssen DE, Müller F, Oktedalen O, Frøland SS, Fausa O, Halstensen TS, Brandtzaeg P (1996)
Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS
J Virol, 70 (6), 3545-50
DOI 10.1128/JVI.70.6.3545-3550.1996, PubMed 8648688
Schrumpf E, Bjøro K, Bell H, Harthug S, Hellum KB, Myrvang B, Maeland A, Ritland S (1996)
[Treatment of hepatitis C]
Tidsskr Nor Laegeforen, 116 (15), 1792-4
PubMed 8693463

Publications 1995

Bjøro K, Krarup H, Bell H, Christophersen P, Evensen S, Frøland SS, Laursen A, B vd Lippe B, Maeland A, Ranek L (1995)
Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices
Scand J Gastroenterol, 30 (11), 1119-24
DOI 10.3109/00365529509101617, PubMed 8578174

Publications 1994

Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T (1994)
Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations
J Infect Dis, 169 (4), 730-8
DOI 10.1093/infdis/169.4.730, PubMed 7907640

Publications 1993

Sandven P, Bjørneklett A, Maeland A (1993)
Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group
Antimicrob Agents Chemother, 37 (11), 2443-8
DOI 10.1128/AAC.37.11.2443, PubMed 8285631

Publications 1992

Larsen J, Skaug K, Maeland A (1992)
Second-generation anti-HCV tests predict infectivity
Vox Sang, 63 (1), 39-42
DOI 10.1111/j.1423-0410.1992.tb01216.x, PubMed 1384236
NORRBY SR, GOTZSCHE PC, MELANDER H, ANDERSEN P, LAHDEVIRTA J, GUDMUNDSSON S, BRUUN JN, BERGLUND O, SKINHOJ P, GERSTOFT J, THYBO S, GIEMSING P, SOEBERG B, ISAGER H, MOLLER A, KROON S, MAELAND A, DOBLOUG JH, FROLAND S, SCHREINER A, HELLUM KB, LINDBACK S, JACOBSSON B, PEHRSON PO, SKOLDENBERG B et al. (1992)
DOUBLE-BLIND DOSE-RESPONSE STUDY OF ZIDOVUDINE IN AIDS AND ADVANCED HIV-INFECTION
Br. Med. J., 304 (6818), 13-17

Publications 1991

BRANDTZAEG P, WAAGE A, MOLLNES TE, OKTEDALEN O, KIERULF P (1991)
SEVERE HUMAN SEPTIC SHOCK INVOLVES MORE THAN TUMOR-NECROSIS-FACTOR
Prog.Clin.Biol.Res., 367, 25-42
Brandtzaeg P, Waage A, Mollnes TE, Oktedalen O, Kierulf P (1991)
Severe human septic shock involves more than tumor necrosis factor
Prog Clin Biol Res, 367, 25-42
PubMed 1924430
Larsen J, Hetland G, Skaug K, Maeland A (1991)
[Viral hepatitis and blood transfusion]
Tidsskr Nor Laegeforen, 111 (7), 825-8
PubMed 1850559
Larsen J, Skaug K, Maeland A, Hetland G, Stoervold G (1991)
Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis
Transfus Med, 1 (1), 13-6
DOI 10.1111/j.1365-3148.1991.tb00003.x, PubMed 9259821
MAELAND A (1991)
SYSTEMIC CANDIDA INFECTIONS
Curr. Med. Res. Opin., 12 1, 26-31
OKTEDALEN O, NYGARD K, OSNES M (1991)
TREATING A PATIENT WITH PANCREATIC ASCITES BY AN INTRAVENOUS-INFUSION OF A SOMATOSTATIN ANALOG - REPLY
Gastroenterology, 100 (6), 1785
DOI 10.1016/0016-5085(91)90697-J

Publications 1989

MAELAND A, SKAUG K, STORVOLD G, KITTELSEN P (1989)
REACTIVATION OF HEPATITIS-B
Lancet, 1 (8646), 1083

Publications 1988

Maeland A (1988)
[Acute HIV disease]
Tidsskr Nor Laegeforen, 108 (22), 1619-20, 1654
PubMed 3413748